Skip to main content

1 in 5 insulin users on Medicare has ‘catastrophic’ drug spending, Yale finds. The Inflation Reduction Act may help

Senate passed bill limiting out-of-pocket spending on insulin to $35 per month for Medicare beneficiaries. Other patients still face high costs for treatment.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.